Patents by Inventor Bengt-Ake Bengtsson

Bengt-Ake Bengtsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230017860
    Abstract: Methods, apparatus and systems for pre-fault detection of hardware degradation; when embodied in a radio base station (RBS) of a wireless communications network, the method is characterized by: sensing at least a portion of an electrical waveform at a circuit location in the RBS; determining the radio resource load of the RBS proximate to the time of sensing the electrical waveform, the radio resource load being a measure of scheduled radio transmissions; determining whether the sensed electrical waveform is within a nominal operating window corresponding to the radio resource load, wherein the nominal operating window is a function of the sensed electrical waveform for the radio resource load at a prior time; and, if the sensed electrical waveform is not within the corresponding nominal operating window, triggering an alarm to indicate that the hardware has reached a degradation limit.
    Type: Application
    Filed: December 18, 2019
    Publication date: January 19, 2023
    Applicant: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Lackis ELEFTHERIADIS, Bengt-Ake BENGTSSON
  • Publication number: 20070066519
    Abstract: The invention relates to the use of a substance, which binds to and initiates signaling of the human growth hormone (hGH) receptor or a substance, which stimulates release or potentiates the activity of endogenous hGH, for treatment and/or prevention of Parkinsonism-Plus Syndromes. In particular, the invention relates to the use of hGH for the treatment and/or prevention of Multiple System Atrophy.
    Type: Application
    Filed: July 29, 2003
    Publication date: March 22, 2007
    Applicant: ARES TRADING S.A.
    Inventor: Bengt-Ake Bengtsson
  • Publication number: 20040180833
    Abstract: A method for treating a patient having Metabolic Syndrome comprising Primary Insulin Resistance and exhibiting lipoprotein aberrations or hypertension comprises administering to said patient human growth hormone or a functional analog thereof in an amount effective for decreasing lipoprotein aberrations or hypertension of said patient.
    Type: Application
    Filed: March 25, 2004
    Publication date: September 16, 2004
    Inventors: Gudmundur Johannsson, Per Marin, Lars Lonn, Malin Ottosson, Kaj Stenlof, Per Bjorntorp, Lars Sjostrom, Bengt-Ake Bengtsson